Cancer Stem Cell Dynamics in Glioblastoma

Glioblastoma is a highly aggressive primary brain tumour characterised by rapid growth, diffuse infiltration and almost inevitable recurrence. A subpopulation of cells within these tumours, known as cancer stem cells (CSCs), possesses the capacity for self-renewal, multilineage differentiation and resistance to standard therapies. Rather than existing as a rigid hierarchy, CSCs in glioblastoma display dynamic interconversion with more differentiated tumour cells, driven by intrinsic genetic programmes and extrinsic signals from the surrounding microenvironment. This cellular plasticity underpins tumour heterogeneity and complicates efforts to eradicate all tumourigenic cells. Key regulatory pathways—including Notch, Wnt and PI3K-AKT—alongside metabolic adaptations and niche interactions with endothelial, immune and stromal cells, sustain CSC survival and promote treatment resistance. Understanding the balance between CSC maintenance, differentiation and reversible state transitions is critical for the development of therapies that prevent repopulation of the tumour by resilient stem-like cells.

Research from Nature Portfolio

Recent studies have revealed that stem-like cells in glioblastoma represent a transient, plastic state rather than a fixed subpopulation defined by particular markers. Phenotypic heterogeneity arises through reversible state transitions that are governed by local niche factors and cell-intrinsic programmes. Mathematical modelling of these transitions has shown that rapid reconstitution of heterogeneity confers a growth advantage in vivo. Importantly, functional assays demonstrate that any tumour cell can acquire stem-like properties under permissive conditions, suggesting that targeting marker-defined CSCs alone is unlikely to achieve durable tumour control. Instead, interventions that disrupt the underlying plasticity network or modify the microenvironmental cues instructing state changes may prove more effective.

Cancer Stem Cell Dynamics in Glioblastoma publication trend

The graph below shows the total number of articles in cancer stem cell dynamics in glioblastoma across all publications each year (not limited to Nature Index journals).

Technical terms

Cancer stem cell (CSC): A tumour-initiating cell with self-renewal capacity and the ability to generate heterogeneous progeny.

Plasticity: The ability of cancer cells to reversibly transition between differentiated and stem-like states.

Microenvironment: The surrounding cellular and molecular context, including blood vessels, immune cells and extracellular matrix, that influences tumour behaviour.

Chemoresistance: The capacity of cancer cells to withstand or adapt to chemotherapeutic agents, often mediated by survival pathways.

Progenitor cell: A partially differentiated cell derived from a stem cell, with limited proliferative potential and lineage restriction.

References

1. Identification of PDLIM1 as a glioblastoma stem cell marker driving tumorigenesis and chemoresistance. Cell Death Discovery (2024).
2. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nature Communications (2019).
3. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma. Cells (2021).
4. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduction and Targeted Therapy (2021).